Pediatric emergency department visits during the COVID-19 pandemic: a large retrospective population-based study

Claudio Barbiellini Amidei1, Alessandra Buja2, Andrea Bardin1

  • 1Department of Cardiologic, Vascular and Thoracic Sciences and Public Health, University of Padova, Via Loredan, 18, 35131, Padova, Italy.

Insights

Pediatric Emergency Department visits significantly decreased during the COVID-19 pandemic due to lockdowns and fear of contagion. Public health must ensure continued access to care for children

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic strained global healthcare, reducing emergency department (ED) visits.
  • Limited data exists on the pandemic's impact on pediatric ED utilization.
  • Fear of contagion and lockdowns deterred parents from seeking medical care.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic on pediatric emergency department visits.
  • To examine changes in visit characteristics and patient acuity during the pandemic.

Main Methods:

  • Retrospective analysis of anonymized pediatric ED visit data (≤14 years) in Veneto, Italy, from 2019 to 2020.
  • Compared year-on-year variations in visit volume, arrival mode, triage codes, clinical presentation, and discharge disposition.
  • Examined trends during the first and second pandemic waves.

Main Results:

  • Total pediatric ED visits decreased by 48% in 2020 compared to 2019, with sharper declines during pandemic waves.
  • Non-urgent visits reduced more significantly than urgent visits.
  • Increased ambulance use and a higher proportion of critical triage codes and hospitalizations were observed in 2020.

Conclusions:

  • Pediatric ED visits declined more steeply than adult visits during the COVID-19 pandemic.
  • Parental fear of contagion and public health restrictions likely reduced care-seeking behavior.
  • Ensuring access to pediatric care, both urgent and non-urgent, is crucial to mitigate pandemic-related health consequences.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
36
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
23
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
27
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
70
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
32